MiniPRO™ - Independent Control of up to 24 Cultures for Scalable, Closed-System Cell Therapy DevelopmentCAMARILLO, Calif., Dec. 2, 2025 /PRNewswire/…
ARLINGTON, Va., Dec. 2, 2025 /PRNewswire/ -- Bluesight, the leader in healthcare intelligence and pharmacy operations, today announced it has…
These trends underscore a need for health organizations to adapt to macroeconomic and regulatory pressures, while prioritizing investments in safeguarding…
STUART, Fla., Dec. 2, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology,…
NORTHAMPTON, MA / ACCESS Newswire / December 2, 2025 / Approximately 129 million Americans are living with at least one…
Co-led by SemperVirens Venture Capital and Next Ventures, with participation by Sanofi Ventures, Lux Capital, Civilization Ventures, How Women Invest…
MESA, ARIZONA / ACCESS Newswire / December 2, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) announced today that the…
VANCOUVER, BC / ACCESS Newswire / December 2, 2025 / StimCell Energetics Inc. (OTCQB:STME) ("StimCell" or the "Company"), a biotech…
Calgary, Alberta--(Newsfile Corp. - December 2, 2025) - Hemostemix (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is proud to announce its…
MILAN, Dec. 02, 2025 (GLOBE NEWSWIRE) -- BetaGlue® Therapeutics (“BetaGlue” or the “Company”) a pioneering Italian clinical-stage oncology company developing…